Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice.
暂无分享,去创建一个
H D Suit | S. Skates | A. Zietman | R. Fabian | H. Suit | S Skates | A Zietman | S Lauk | R Fabian | S. Lauk
[1] D. Chaplin. Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT). , 1986, British Journal of Cancer.
[2] A. Zietman,et al. Quantitative transplantation assays of spontaneous tumors of the C3H mouse as allografts in athymic NCr/Sed-nu/nu nude mice and isografts in C3Hf/Sed mice. , 1988, Cancer research.
[3] S. Lauk. Endothelial alkaline phosphatase activity loss as an early stage in the development of radiation-induced heart disease in rats. , 1987, Radiation research.
[4] P Vaupel,et al. Blood flow, oxygen consumption, and tissue oxygenation of human breast cancer xenografts in nude rats. , 1987, Cancer research.
[5] N. Fusenig,et al. Preservation of morphological, functional, and karyotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas. , 1983, Cancer research.
[6] E. Butcher,et al. Lymphoid tissue- and inflammation-specific endothelial cell differentiation defined by monoclonal antibodies. , 1987, Journal of immunology.
[7] R K Jain,et al. Determinants of tumor blood flow: a review. , 1988, Cancer research.
[8] H. Koch,et al. Mikroangiographische Untersuchungen verschiedener menschlicher Tumoren nach Transplantation auf thymusaplastische Nacktmäuse , 1983 .
[9] I. Tannock. Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor. , 1970, Cancer research.
[10] E. Rofstad,et al. Vascular structure of five human malignant melanomas grown in athymic nude mice. , 1982, British Journal of Cancer.
[11] R. Sutherland. Importance of critical metabolites and cellular interactions in the biology of microregions of tumors , 1986, Cancer.
[12] K. Smith,et al. Vascular markers for murine tumours. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] G. Adams,et al. Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine. , 1988, British Journal of Cancer.